Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|January 18, 2006
Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemiaJudith M Leitner, Christa Firbas, Florian B Mayr, et al.
Thrombosis Research|April 25, 2008
Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammationAlexander O Spiel, Florian B Mayr, Judith M Leitner, et al.
Frontiers in Medicine|January 6, 2025
Very low doses of rituximab in autoimmune hemolytic anemia-an open-label, phase II pilot trialMiriam M Moser, Renate Thalhammer, Christian Sillaber, et al.
Thrombosis and Haemostasis|February 9, 2011
Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration. A randomised controlled trialAlexander O Spiel, Johann Bartko, Michael Schwameis, et al.
British Journal of Clinical Pharmacology|January 9, 2020
Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose-escalating trialNina Buchtele, Michael Schwameis, Christian Schoergenhofer, et al.
Thrombosis and Haemostasis|June 3, 2020
Differential Osteoprotegerin Kinetics after Stimulation with Desmopressin and Lipopolysaccharides In VivoNina Buchtele, Katarina D Kovacevic, Christine Brostjan, et al.
Thrombosis and Haemostasis|January 18, 2006
The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemiaAlexander O Spiel, Christa Firbas, Florian B Mayr, et al.
Critical Care Medicine|November 17, 2007
Duffy antigen modifies the chemokine response in human endotoxemiaFlorian B Mayr, Alexander O Spiel, Judith M Leitner, et al.
Pageof 5